SE7612962L - Tienamycinderivat - Google Patents

Tienamycinderivat

Info

Publication number
SE7612962L
SE7612962L SE7612962A SE7612962A SE7612962L SE 7612962 L SE7612962 L SE 7612962L SE 7612962 A SE7612962 A SE 7612962A SE 7612962 A SE7612962 A SE 7612962A SE 7612962 L SE7612962 L SE 7612962L
Authority
SE
Sweden
Prior art keywords
derivatives
tienamycin
disclosed
antibiotic
compositions
Prior art date
Application number
SE7612962A
Other languages
English (en)
Inventor
B G Christensen
J Hannah
W J Leanza
D H-M Shih
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7612962L publication Critical patent/SE7612962L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7612962A 1975-11-21 1976-11-19 Tienamycinderivat SE7612962L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63429575A 1975-11-21 1975-11-21

Publications (1)

Publication Number Publication Date
SE7612962L true SE7612962L (sv) 1977-05-22

Family

ID=24543215

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7612962A SE7612962L (sv) 1975-11-21 1976-11-19 Tienamycinderivat

Country Status (9)

Country Link
US (1) US4397861A (sv)
JP (1) JPS5277084A (sv)
CH (1) CH632508A5 (sv)
DE (1) DE2652674A1 (sv)
DK (1) DK523476A (sv)
FR (1) FR2332013A1 (sv)
GB (1) GB1570989A (sv)
NL (1) NL7612941A (sv)
SE (1) SE7612962L (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839352A (en) * 1975-11-21 1989-06-13 Merck & Co., Inc. N-acyl derivatives of thienamycin
US4235917A (en) * 1977-05-05 1980-11-25 Merck & Co., Inc. N-Alkyl-N-acyl derivatives of thienamycin
EP0004132A1 (en) * 1978-03-04 1979-09-19 Beecham Group Plc Esters of beta-lactam antibiotics, a process for their preparation pharmaceutical compositions containing them and the compounds for use as antibacterial agents
JPS565457A (en) * 1979-06-27 1981-01-20 Dai Ichi Seiyaku Co Ltd Thienamycin intermediate
DK456580A (da) * 1979-10-29 1981-06-04 Beecham Group Ltd Fremgangsmaade til fremstilling af bicycliske beta-lactamringholdige forbindelser
US4426390A (en) * 1980-10-01 1984-01-17 Sanraku-Ocean Co., Ltd. Novel β-lactam compounds, process for producing thereof, and use thereof as medicines
DE3277622D1 (en) * 1981-07-01 1987-12-17 Sanraku Inc Novel antibiotics and process for production thereof
JPS5857392A (ja) * 1981-10-02 1983-04-05 Sanraku Inc 新規な抗生物質ｏａ−６１２９のリン酸エステル
US4992542A (en) * 1984-01-24 1991-02-12 Merck & Co., Inc. 2-substituted-6-carbadethiapen-2-em-3-carboxylic acids
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1004670A (en) * 1963-04-23 1965-09-15 Beecham Res Lab Penicillins
GB1348985A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds
US4165379A (en) * 1975-11-21 1979-08-21 Merck & Co., Inc. N-acetyl thienamycin
US4162324A (en) * 1975-11-21 1979-07-24 Merck & Co., Inc. Antibiotics 890A1 and 890A3

Also Published As

Publication number Publication date
FR2332013B1 (sv) 1978-12-29
JPS6259107B2 (sv) 1987-12-09
GB1570989A (en) 1980-07-09
DK523476A (da) 1977-05-22
JPS5277084A (en) 1977-06-29
DE2652674A1 (de) 1977-06-02
NL7612941A (nl) 1977-05-24
FR2332013A1 (fr) 1977-06-17
CH632508A5 (de) 1982-10-15
US4397861A (en) 1983-08-09

Similar Documents

Publication Publication Date Title
ES477591A1 (es) Procedimiento para la obtencion de preparados farmaceuticos que contienen un derivado de cefem.
IE792028L (en) Pyrroloazetidinones
GB2037745B (en) Diphenylbutyl - piperazinecarboxamides
DE3163802D1 (en) Cephalosporin derivatives, pharmaceutical compositions and process for their preparation
AU499034B2 (en) Treatment of schizophrenia using admixture of neuroleptic drug and gabergic compound
ES469425A1 (es) Un procedimiento para la preparacion de derivados de tiena- micina
ES476109A1 (es) Procedimiento para la preparacion de derivados de cefalospo-rina
SE7608092L (sv) Nya steroider
SE7612962L (sv) Tienamycinderivat
ES425514A1 (es) Un procedimiento para la preparacion de nuevas 3-nitrocuma-rinas.
ES2136591T3 (es) Derivados de cefalosporina y procedimiento para su preparacion.
IL35875A (en) Pharmaceutical compositions for the treatment of microbial infections containing an n-(3-carboxy-propionyl)glutamic acid derivative
DE3371515D1 (en) Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
CA950833A (en) Composition for the treatment of hypertrophied oral tissue
DE2963665D1 (en) Cephem derivatives, process for their preparation and pharmaceutical compositions containing them
SE7612295L (sv) Antibiotikum
SE7612963L (sv) Tienamycinderivat
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
SE7612960L (sv) Tienamycinderivat
SE8404556L (sv) Farmaceutisk komposition
ES469426A1 (es) Un procedimiento para la preparacion de derivados n-al- quil-n-iminometilicos de tienamicina
ES415069A1 (es) Un procedimiento para la preparacion de esteres aminoalqui-licos de penicilinas y cefalosporinas.
AU460683B2 (en) New pharmaceutical compositions for the treatment of microbial infections
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7612962-6

Format of ref document f/p: F